Rapid molecular diagnosis of ALB gene variants prevents unnecessary interventions in familial dysalbuminemic hyperthyroxinemia

J Pediatr Endocrinol Metab. 2021 Jun 18;34(9):1201-1205. doi: 10.1515/jpem-2021-0087. Print 2021 Sep 27.

Abstract

Objectives: Familial dysalbuminemic hyperthyroxinemia (FDH) is an autosomal dominant condition caused by heterozygous gain-of-function mutations in the human ALB gene.

Case presentation: We report, a three-year-old boy with FDH due to p.R242P (or p.R218P without signal peptide) mutation in the ALB gene with a phenotype characterized by extremely high serum total and free thyroxine concentrations. His parents had normal thyroid function tests (TFT), so the mutation detected in this patient is assumed "de novo". Although the most frequent variant was p.R242H in Caucasians and p.R242P in Japanese, our patient had p.R242P variant.

Conclusions: Early identification of FDH is fundamental to prevent unnecessary repeats of TFT with different methods. We encourage the ALB gene hot spot sequencing initially and indicate that this molecular diagnosis is a rapid and simple method to diagnose FDH in individuals with euthyroid hyperthyroxinemia.

Keywords: ALB gene; albumin; familial dysalbuminemic hyperthyroxinemia; hyperthyroxinemia; thyroid hormone resistance.

Publication types

  • Case Reports

MeSH terms

  • Child, Preschool
  • Humans
  • Hyperthyroxinemia, Familial Dysalbuminemic / diagnosis*
  • Hyperthyroxinemia, Familial Dysalbuminemic / genetics
  • Male
  • Mutation*
  • Prognosis
  • Serum Albumin, Human / genetics*

Substances

  • ALB protein, human
  • Serum Albumin, Human